Latest Isologic News
News, Insight, Education – Welcome to the Isologic Blog
Isologic Launches Illuccix® PSMA PET Imaging Agent to Detect Prostate Cancer
Montreal, March 16th, 2023 – Isologic Innovative Radiopharmaceuticals is proud to announce that the prostate cancer imaging agent Illuccix®, Ga 68 Gozetotide Preparation Kit, also known as PSMA-11, is now available in Canada. 24,000 men are diagnosed with prostate cancer each year in Canada, making it the number one cancer [...]
Telix and Isologic sign License and Distribution Agreement for Illuccix® for Canada
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed a license and distribution agreement with Isologic Innovative Pharmaceuticals Ltd (Isologic) for the commercialisation of Telix’s investigational prostate cancer imaging agent, Illuccix® (kit for preparation of gallium Ga-68 gozetotide injection), also known as 68Ga-PSMA-11 injection, for the Canadian [...]
Isologic Innovatives pharmaceuticals seminar-SNMMI annual conference- June 2022
Our scientific event organized on June 13, 2022 during the SNMMI annual conference was a great success, We thank all the experts who accepted our invitation and took part in this seminar dedicated to PET imaging agents. Two international experts offered an overview of prostate and brain cancer imaging to [...]
CPDC, New acquisition
Dear customers, We are pleased to announce that Isologic has just completed the acquisition of the FDG Canadian distribution business from Centre for Probe Development and Commercialization (CPDC). As a result, all FDG customers serviced by CPDC are, effective December 1st, serviced by Isologic out of our Toronto (Sunnybrook) facility. [...]
Facility Disclosure
Facility Disclosure
NEW PRODUCT AVAILABLE
Antimony Sulfide Colloid Tc99m injection January 9th, 2020 Dear Valued Customer, It is with great pleasure that we would like to inform you that Isologic has a new product within its portfolio. We are introducing Antimony Sulfide Colloid Tc99m injection. This product is indicated for use as [...]
General Nuclear Medicine News
News and Education provided by World Leading Experts
Isologic Launches Illuccix® PSMA PET Imaging Agent to Detect Prostate Cancer
Montreal, March 16th, 2023 – Isologic Innovative Radiopharmaceuticals is proud to announce that the prostate cancer imaging agent Illuccix®, Ga 68 Gozetotide Preparation Kit, also known as PSMA-11, is now available in Canada. 24,000 men are diagnosed with prostate cancer each year in Canada, making it the number one cancer [...]
Telix and Isologic sign License and Distribution Agreement for Illuccix® for Canada
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed a license and distribution agreement with Isologic Innovative Pharmaceuticals Ltd (Isologic) for the commercialisation of Telix’s investigational prostate cancer imaging agent, Illuccix® (kit for preparation of gallium Ga-68 gozetotide injection), also known as 68Ga-PSMA-11 injection, for the Canadian [...]
Invitation
Invitation Special invitation, Monday June 24, 2019 As part of the SNMMI annual conference to be held from June 22 to June 25, ISOLOGIC invites you to a seminar dedicated to innovative radiopharmaceutical services and the production of PET imaging agents. ****First come first serve**** View invitation [...]
First diagnostic radiotracer for early diagnosis of Alzheimer’s disease approved in Canada
PIRAMAL IMAGING SA AND ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS ANNOUNCE COMMERCIAL APPROVAL OF NEURACEQ™ BY HEALTH CANADA MONTREAL, Feb. 28, 2017 /CNW Telbec Piramal Imaging SA and ISOLOGIC Innovative Radiopharmaceuticals today announce that Health Canada has issued a Notice of Compliance (NOC) [...]
IRE-ELiT S.A. & Isologic Sign Exclusive Agreement
IRE-ELiT S.A. (Environment & Lifescience Technology) & Isologic signed an exclusive agreement for the distribution of Galli Eo™ 68Ge/ 68Ga generator in Canada FLEURUS, Belgium ; Montreal, Canada ; the 31st January. IRE-ELiT S.A. (Environment & Lifescience Technology) & Isologic Innovative Radiopharmaceuticals, the [...]
Statement on Reports of a Medical Isotope Shortage
Statement on Reports of a Medical Isotope Shortage Recently, there has been several public announcements in print and on Canadian television & radio regarding an upcoming shortage in the supply of medical isotopes. In these reactionary articles, while based on the [...]
ISOLOGIC Acquires Lantheus Canadian Imaging Centres
ISOLOGIC Acquires Lantheus Canadian Imaging Centres ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS ACQUIRES LANTHEUS MEDICAL IMAGING CANADIAN RADIOPHARMACEUTICAL CENTRES ISOLOGIC is pleased to announce the completion of an asset purchase agreement for the acquisition of the Canadian radiopharmacy and Gludef manufacturing and [...]